Skip to content

Chief Executive John Glencross featured on BBC Newsnight

John Glencross was asked by BBC Newsnight to comment on the position for investors during the ongoing Brexit negotiations. To watch the short clip please see below. [youtube id=”StTC1jD2Emc” align=”center” mode=”normal” autoplay=”no”]

Leo de Montaignac, CEO of Weedingtech: Public concern over chemical herbicides

Calculus Capital portfolio company CEO, Leo de Montaignac of Weedingtech writes for The Parliament Magazine around the use of glyphosate in public and urban spaces. The primary objective for their product Foamstream was to offer an effective, affordable commercial product as an alternative to traditional chemical herbicides like glyphosate, which could be used in public … Continued

Spotlight On: Blu Wireless Technology

As part of our ‘Spotlight On’ series, we focus on Blu Wireless Technology a technology company, developing semiconductor designs for the next generation of high speed wireless data transfer. Calculus Capital completed a £2.4m investment in Blu Wireless (‘BWT’) in June 2017, as the cornerstone investor in a £7.2 million institutional and private investment round in conjunction … Continued

Spotlight On: AnTech

As part of our ‘Spotlight On’ series, we focus on AnTech a specialist engineering company in the oil and gas industry. AnTech Limited has two different businesses: manufacturing products for use mainly in oil and gas production (as opposed to drilling) and providing directional coil drilling services. AnTech’s Products Division supplies high specification customised and standard products; … Continued

C4X awarded grant from the US National Institute on Drug Abuse (NIDA)

C4X recently announced that their C4X3256 programme has been awarded a grant from the National Institute on Drug Abuse (NIDA, a division of National Institute of Health (NIH)). The grant of approximately $480k will support the pre-clinical development of C4X3256 in cocaine use disorder, an additional addiction indication with high unmet need. Recently licensed to Indivior, C4X3256, an … Continued

Benito’s Hat News Article in Today’s City AM

News of Benito’s Hat growth investment makes the headlines in this morning’s publication of City AM! Read more via the link below. Benito's Hat eyes expansion after securing new funding — City A.M. (@CityAM) August 6, 2018

Mologic announces diagnostic clinical trial for Cystic Fibrosis

Calculus Capital portfolio company Mologic announced today that they have commenced a clinical trial to evaluate the company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients. The study aims to identify five urinary biomarkers associated with the onset of pulmonary exacerbation in adults with CF. It will also validate the use … Continued